ANI Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Director or officer changeAug 24 →InsidersNo open-market buys. 11 insiders sold $12.7M, 22 of 36 sales on a 10b5-1 plan.→Financing →PeersClosest companies: AMPH, HRTX, AMRX→
From the filings
Figures
- Revenue
- $978.4Mlast 12 months
- Net income
- $108.0Mlast 12 months
- Operating cash flow
- $208.6Mlast 12 months
- Cash and equivalents
- $360.2Mat the last balance sheet
- Total debt
- $301.5Mat the last balance sheet
- Shares outstanding
- 22.5M shareson issue